Lineage Cell Therapeutics (LCTX) Institutional Ownership $0.47 -0.02 (-3.84%) As of 12:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)CurrentInstitutional OwnershipPercentage62.47%Number ofInstitutional Buyers(last 12 months)29TotalInstitutional Inflows(last 12 months)$6.14MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$170.28K Get LCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lineage Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LCTX Institutional Buying and Selling by Quarter Remove Ads Lineage Cell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC92,001$46K0.0%N/A0.042% 2/17/2025 Two Sigma Advisers LP86,964$44K0.0%+312.2%0.039% 2/17/2025 Two Sigma Investments LP301,544$152K0.0%N/A0.137% 2/17/2025 Jacobs Levy Equity Management Inc.1,033,763$519K0.0%N/A0.469% 2/17/2025 Deutsche Bank AG174,702$87K0.0%+196.0%0.079% 2/17/2025 DAFNA Capital Management LLC2,511,374$1.26M0.3%+85.9%1.139% 2/17/2025 Bridgeway Capital Management LLC417,900$210K0.0%-44.8%0.190% 2/17/2025 Alyeska Investment Group L.P.3,947,369$1.98M0.0%N/A1.791% 2/14/2025 Jane Street Group LLC262,866$132K0.0%+119.2%0.119% 2/14/2025 Raffles Associates LP5,492,088$2.76M3.0%+21.8%2.492% Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025 Comerica Bank800,000$402K0.0%+220.0%0.363% 2/13/2025 Barclays PLC234,069$118K0.0%+10.8%0.106% 2/13/2025 Renaissance Technologies LLC2,283,072$1.15M0.0%+1,058.3%1.036% 2/13/2025 Wells Fargo & Company MN94,894$48K0.0%+33.0%0.043% 2/12/2025 JPMorgan Chase & Co.946,399$476K0.0%+39.8%0.429% 2/7/2025 HighTower Advisors LLC57,706$29K0.0%+49.5%0.026% 2/5/2025 Fort Sheridan Advisors LLC55,177$28K0.0%+71.5%0.025% 2/5/2025 Red Crane Wealth Management LLC340,236$171K0.2%N/A0.154% 1/31/2025 Atria Wealth Solutions Inc.57,423$29K0.0%N/A0.026% 1/23/2025 Defender Capital LLC.5,963,348$3.00M1.1%+19.2%2.705% 1/17/2025 SG Americas Securities LLC68,973$35K0.0%+35.5%0.031% 12/26/2024 JPMorgan Chase & Co.677,162$613K0.0%+13.9%0.307% 11/19/2024 Barclays PLC211,300$192K0.0%+311.3%0.096% 11/16/2024 Geode Capital Management LLC3,679,280$3.33M0.0%+2.3%1.948% 11/15/2024 Barclays PLC211,300$192K0.0%+311.3%0.112% 11/15/2024 Jane Street Group LLC119,901$109K0.0%-50.6%0.063% 11/15/2024 State Street Corp2,608,352$2.36M0.0%+1.8%1.381% 11/15/2024 HighTower Advisors LLC38,606$35K0.0%-30.7%0.020% 11/14/2024 Raffles Associates LP4,507,781$4.08M4.2%+3.4%2.387% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.191,436$173K0.0%-7.9%0.101% 11/7/2024 MAI Capital Management1,674,679$1.52M0.0%+2.2%0.887% 11/5/2024 GSA Capital Partners LLP93,032$84K0.0%N/A0.049% 10/21/2024 Defender Capital LLC.5,002,198$4.53M1.5%+0.6%2.649% 10/3/2024 SG Americas Securities LLC50,920$46K0.0%N/A0.027% 8/27/2024 Logos Global Management LP4,700,000$4.69M0.4%-24.8%2.489% 8/14/2024 Raffles Associates LP4,357,781$4.35M4.9%+35.8%2.308% 8/14/2024 Logos Global Management LP4,700,000$4.69M0.4%-24.8%2.489% 8/12/2024 XTX Topco Ltd61,515$61K0.0%N/A0.033% 8/9/2024 Renaissance Technologies LLC583,622$582K0.0%+10.0%0.309% 8/1/2024 Rhumbline Advisers132,491$132K0.0%+15.1%0.070% The unusual signal flashing green again (Ad)Something fascinating happened in April... While a lot of Wall Street institutions were opening new positions in a falling stock, something different showed up on my screen. A special set of candles had just turned green - signaling the kind of momentum surge I'd seen only a handful of times before. What happened next? The stock soared 45% on the underlying stock in just a few weeks and 227% for anyone who traded the options. Naturally, there would have been smaller wins and those that would not have worked out, but this wasn't some penny stock or crypto play… It was ARM Holdings - a major semiconductor player that had just shed 9% of its value.I’ve put together everything you need to know here.7/26/2024 Bank of New York Mellon Corp435,958$435K0.0%+35.7%0.231% 5/17/2024 Comerica Bank250,295$370K0.0%+84,745.8%0.133% 5/15/2024 Price T Rowe Associates Inc. MD161,314$239K0.0%+77.5%0.085% 5/10/2024 Vanguard Group Inc.8,373,771$12.39M0.0%-0.1%4.435% 4/16/2024 Fifth Third Wealth Advisors LLC20,000$30K0.0%N/A0.011% 2/13/2024 DCF Advisers LLC94,751$103K0.1%+14.5%0.054% 1/23/2024 Defender Capital LLC.4,969,675$5.42M1.9%-4.1%2.840% 1/12/2024 SG Americas Securities LLC30,889$34K0.0%+61.6%0.018% 12/6/2023 Citigroup Inc.133,051$157K0.0%-16.2%0.076% 11/15/2023 Laurion Capital Management LP1,136,471$1.34M0.0%-42.2%0.649% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.182,561$215K0.0%-27.9%0.104% 11/13/2023 Rathbones Group PLC35,000$41K0.0%N/A0.020% 10/23/2023 Defender Capital LLC.5,184,510$6.12M2.2%+1.5%2.963% 9/21/2023 Barclays PLC25,905$36K0.0%+87.3%0.015% 8/15/2023 Raffles Associates LP1,597,739$2.25M3.0%+4.0%0.913% 8/4/2023 American International Group Inc.62,114$88K0.0%N/A0.036% 8/2/2023 MAI Capital Management951,578$1.34M0.0%+123.8%0.545% 8/1/2023 Fort Sheridan Advisors LLC83,931$118K0.0%+13.5%0.049% 7/18/2023 Defender Capital LLC.5,109,710$7.20M2.5%-0.5%3.003% 7/10/2023 Trust Co. of Toledo NA OH35,394$50K0.0%+41.6%0.021% 6/1/2023 Prelude Capital Management LLC16,688$25K0.0%N/A0.010% 5/15/2023 Fort Sheridan Advisors LLC73,931$111K0.0%-11.9%0.043% 5/12/2023 Long Focus Capital Management LLC175,000$262K0.0%-18.6%0.103% 5/11/2023 PFG Investments LLC20,200$30K0.0%N/A0.012% 5/10/2023 Summit X LLC21,925$33K0.0%-26.7%0.013% 5/10/2023 MAI Capital Management425,115$638K0.0%-6.9%0.250% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.241,022$362K0.0%-8.0%0.142% 5/9/2023 Y Intercept Hong Kong Ltd66,298$99K0.0%N/A0.039% 5/5/2023 Truist Financial Corp42,591$64K0.0%N/A0.025% 5/1/2023 Virtu Financial LLC17,521$26K0.0%-60.6%0.010% 4/27/2023 Defender Capital LLC.5,136,085$7.70M2.7%+0.8%3.019% 4/27/2023Simplicity Solutions LLC48,000$72K0.0%N/A0.028% 4/20/2023 Strategic Wealth Investment Group LLC18,553$47K0.0%-41.2%0.011% 4/18/2023ETF Managers Group LLC318,596$478K0.0%-10.0%0.187% 4/4/2023 Trust Co. of Toledo NA OH25,000$38K0.0%N/A0.015% 3/23/2023ETF Managers Group LLC353,991$414K0.0%+7.3%0.208% 2/14/2023 683 Capital Management LLC128,840$151K0.0%N/A0.076% 2/10/2023 Connor Clark & Lunn Investment Management Ltd.261,902$306K0.0%-9.2%0.154% 2/9/2023 MAI Capital Management456,817$534K0.0%-12.5%0.269% 2/9/2023 Citigroup Inc.477,174$558K0.0%+250.9%0.281% 2/8/2023 Lincoln National Corp155,700$182K0.0%-28.5%0.092% 1/12/2023 Defender Capital LLC.5,093,535$5.96M2.4%-1.7%2.997% 11/15/2022 Laurion Capital Management LP2,377,940$2.69M0.0%-1.8%1.399% 11/15/2022ETF Managers Group LLC329,826$373K0.0%+8.2%0.194% 11/14/2022 Raffles Associates LP2,080,536$2.35M2.5%+7.8%1.226% 11/14/2022 Lazard Asset Management LLC77,974$88K0.0%N/A0.046% 11/14/2022Ergoteles LLC490,895$555K0.0%-11.3%0.289% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.288,299$326K0.0%+113.0%0.170% 11/10/2022 Phoenix Holdings Ltd.47,587$55K0.0%-73.2%0.028% 11/4/2022 Lincoln National Corp217,700$246K0.0%-13.4%0.128% The Dirty Secret About Gold Mining Stocks... (Ad)Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy shareholder value over time. Even as gold prices rise.Right now, I've found 4 miners showing the exact same pattern as previous 100-baggers.10/21/2022 Strategic Wealth Investment Group LLC37,008$42K0.0%-25.6%0.022% 10/18/2022 Defender Capital LLC.5,184,035$5.86M2.3%+1.0%3.054% 8/15/2022 Laurion Capital Management LP2,422,367$3.83M0.1%N/A1.427% 8/10/2022Dowling & Yahnke LLC32,263$51K0.0%N/A0.019% 8/8/2022 Y Intercept Hong Kong Ltd44,829$71K0.0%N/A0.026% 8/8/2022 Strategic Wealth Investment Group LLC49,736$79K0.0%-20.4%0.029% 8/5/2022 Connor Clark & Lunn Investment Management Ltd.135,328$214K0.0%+1,027.7%0.080% 8/2/2022 Lincoln National Corp251,500$397K0.0%+30.4%0.148% 7/26/2022 Defender Capital LLC.5,131,935$8.11M3.2%+2.5%3.024% 7/19/2022 MAI Capital Management247,735$391K0.0%N/A0.146% (Data available from 1/1/2016 forward)Remove Ads LCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LCTX shares? During the previous two years, 49 institutional investors and hedge funds held shares of Lineage Cell Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($12.39M), Logos Global Management LP ($4.69M), Geode Capital Management LLC ($3.33M), Defender Capital LLC. ($3.00M), Raffles Associates LP ($2.76M), State Street Corp ($2.36M), and Alyeska Investment Group L.P. ($1.98M).Learn more on LCTX's institutional investors. What percentage of Lineage Cell Therapeutics stock is owned by institutional investors? 62.47% of Lineage Cell Therapeutics stock is owned by institutional investors. Learn more on LCTX's institutional investor holdings. Which institutional investors have been buying Lineage Cell Therapeutics stock? Of the 38 institutional investors that purchased Lineage Cell Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alyeska Investment Group L.P. ($3.95M), Raffles Associates LP ($2.34M), Renaissance Technologies LLC ($2.14M), DAFNA Capital Management LLC ($1.16M), Defender Capital LLC. ($1.11M), Jacobs Levy Equity Management Inc. ($1.03M), and Comerica Bank ($800K). How much institutional buying is happening at Lineage Cell Therapeutics? Institutional investors have bought a total of 15,916,842 shares in the last 24 months. This purchase volume represents approximately $7.49M in transactions. Which Lineage Cell Therapeutics major shareholders have been selling company stock? Of the 16 institutional investors that sold Lineage Cell Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Logos Global Management LP ($3.10M), Laurion Capital Management LP ($829.78K), Bridgeway Capital Management LLC ($338.87K), Defender Capital LLC. ($241.21K), Jane Street Group LLC ($123.05K), Connor Clark & Lunn Investment Management Ltd. ($107.92K), and Long Focus Capital Management LLC ($40K). How much institutional selling is happening at Lineage Cell Therapeutics? Institutional investors have sold a total of 4,959,524 shares in the last 24 months. This volume of shares sold represents approximately $486.28K in transactions. Related Companies ABIVAX Société Anonyme Major Shareholders Altimmune Major Shareholders Keros Therapeutics Major Shareholders Oruka Therapeutics Major Shareholders Autolus Therapeutics Major Shareholders Tourmaline Bio Major Shareholders Stoke Therapeutics Major Shareholders Ginkgo Bioworks Major Shareholders Zevra Therapeutics Major Shareholders REGENXBIO Major Shareholders This page (NYSEAMERICAN:LCTX) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.